GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
J

Jin Medical International ZJYL · USD

Health Care · US listing · 🇺🇸 United States

Compare

3.95

+17.56%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Jin Medical International

Its shares trade under the ticker ZJYL. It has been listed since 28 March 2023. In the fiscal year to 30 September 2025, it reported revenue of $20.7m and net income of $1.2m. At that date it held total assets of $53.4m and shareholders' equity of $29.6m.

Jin Medical International Ltd. is a holding company, which engages in the design, development, manufacture and sale of wheelchair and other living aids products to be used by people with disabilities or impaired mobility. The company is headquartered in Changzhou, Jiangsu. The company went IPO on 2023-03-28. The Company, through its wholly owned subsidiaries, is primarily engaged in the design, development, manufacturing and sales of wheelchair and other living aids products to be used by people with disabilities or impaired mobility. The firm's wheelchair product category includes mid, high and low-end wheelchairs. The wheelchair components include wheels and brakes, which are sold to customers for after-sales service. The living aids product category consists of oxygen concentrators, bath aids and rehabilitative devices. The firm mainly distributes its products in domestic and overseas markets.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Health Care Equipment & Supplies
Listed since
28 Mar 2023
Employees
269
Head office
NO. 33 LINGXIANG ROAD, WUJIN DISTRICT, JIANGSU PROVINCE, F4, 213149
Incorporated in
E9
Classification
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Filer status
Non-accelerated filer<br>Emerging growth company

Leadership

Pay as last reported

  • Mr. Erqi WangChairman of the Board, Chief Executive Officer, since 2020$62,800
  • Mr. Ziqiang WangChief Financial Officer$44,200
  • Mr. Oliver Clair FranklinIndependent Director Nominee
  • Mr. Jourdan FrainIndependent Director Nominee
  • Ms. Yanru GuoIndependent Director

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • The company designs and manufactures wheelchairs for impaired mobility.
  • It sells oxygen concentrators and bath aids as living aids.
  • Products are distributed in domestic and overseas markets.

Weaknesses

  • The firm employs only 269 full-time staff members.
  • It operates as a holding company with wholly owned subsidiaries.
  • Wheelchair components are sold separately for after-sales service.

Opportunities

  • The company can expand its mid, high, and low-end wheelchair lines.
  • Growing demand exists for rehabilitative devices globally.
  • Overseas markets offer potential for increased product distribution.

Threats

  • The company went public in March 2023, facing market volatility.
  • It competes in the health care sector with other manufacturers.
  • Reliance on specific components like wheels and brakes creates supply risks.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.